FDA 483 - MSN PHARMACEUTICALS INC. - June 16, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
MSN Pharmaceuticals Inc. in Piscataway, NJ, was inspected and received 11 observations primarily related to significant data integrity issues, inadequate quality control, and insufficient documentation for manufacturing processes and product testing. The inspection revealed deficiencies in batch record accuracy, sampling plans, stability studies, water quality, equipment cleaning, personnel training, laboratory controls, and master production records, indicating a broad lack of adherence to GMP standards.
ID · d65cb645-f47f-4d20-9f4d-19427e270589